×

Stable insulin formulations

  • US 6,551,992 B1
  • Filed: 11/29/1999
  • Issued: 04/22/2003
  • Est. Priority Date: 06/13/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A solution formulation comprising:

  • a physiologically tolerated buffer selected from the group consisting of TRIS and arginine;

    a monomeric insulin analog;

    zinc; and

    a phenolic preservative,wherein the formulation is a solution formulation.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×